CUSIP 800677106COMSGMOQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
104 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Vanguard Group Inc | 12.00M | $5.04M | +385.2K | Added |
| 2 | Renaissance Technologies LLC | 8.43M | $3.54M | −1.75M | Reduced |
| 3 | Two Sigma Investments, LP | 4.76M | $2.00M | +2.28M | Added |
| 4 | Blackrock, Inc. | 4.57M | $1.92M |
| +15.6K |
| Added |
| 5 | Two Sigma Advisers, LP | 4.34M | $1.82M | +2.23M | Added |
| 6 | Geode Capital Management, LLC | 3.87M | $1.62M | +579.5K | Added |
| 7 | Jane Street Group, LLC | 2.92M | $1.23M | +717.4K | Added |
| 8 | Susquehanna International Group, LLP | 2.14M | $897.6K | −283.2K | Reduced |
| 9 | Charles Schwab Investment Management Inc | 1.71M | $719.6K | +174.3K | Added |
| 10 | Wasatch Advisors LP | 1.42M | $595.0K | −9.7K | Reduced |
See every fund holding Sangamo Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders